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SUMMARY
Schistosomiasis and soil-transmitted helminthiasis occur throughout the developing world and remain a major public
health problem in the poorest communities with enormous consequences for development. The extent of the problem has
long been neglected because these diseases rarely kill at a young age and also because of their insidious nature. Today there
exists a momentum and an unprecedented opportunity for a cost-eﬀective control of these neglected tropical diseases. The
control of these diseases has become a priority on the agenda of many governments, donors and international agencies. This
paper highlights the progress made and future control activities in Cameroon and Coˆte d’Ivoire, where schistosomiasis and
soil-transmitted helminthiasis control measures have been implemented over the past decade with limited budgets. In
Cameroon, deworming activities were increased to encompass all ten regions in 2007 as a result of a co-ordinated eﬀort of
the Ministry of Health and the Ministry of Education with national and international partners. In Coˆte d’Ivoire, focal
control activities were achieved with support from various partners. Prospects, opportunities and challenges for the control
of neglected tropical diseases in these two countries are discussed.
Key words: Schistosomiasis, soil-transmitted helminthiasis, control, deworming, neglected tropical diseases, Cameroon,
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INTRODUCTION
Schistosomiasis is one of the most prevalent parasitic
diseases in the world. The disease has major health
and socio-economic repercussions and it constitutes
an important public health problem in developing
countries. Schistosomiasis is endemic in 76 countries,
where 779 million people are at risk of infection; it is
estimated that 207 million people are infected. The
disease aﬀects the poorest of the poor and compro-
mises their development (WHO, 2002; Steinmann
et al. 2006). Despite the existence of tools in the
1970s and 1980s, control was sustained for a pro-
longed period only in few countries and almost no
progress wasmade in sub-SaharanAfrican countries,
the most aﬀected part of the world. In the 1990s,
interest in schistosomiasis control in Africa waned.
Therefore, as with other neglected tropical diseases
(NTDs), schistosomiasis control has been over-
shadowed by other health priorities. The highest
priority of the international health community was
given to the ‘big three’, i.e. HIV/AIDS, tuberculosis
and malaria, with less attention to other infections
related to poverty (Molyneux, Hotez and Fenwick,
2005).
Recent years have witnessed an increased interest
in the control of NTDs, and today there exists a
global momentum for the control of these diseases,
as well as an unprecedented opportunity for cost-
eﬀective action. The control of NTDs has become a
priority on the agenda of many governments, donors
and international agencies. The World Health
Organization (WHO) has played a major role in
this prospect. Indeed, under the aegis of WHO, all
member states of WHO (over 200 countries) have
endorsed in May 2001 the World Health Assembly
resolution WHA 54.19, with as a major objective the
regular treatment of at least 75% of all school-aged
children at risk of morbidity by 2010. This com-
mitment has led to a series of events and initiatives
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in favour of the control of worms, in particular the
launching of the ‘Partners for Parasite Control ’
(PPC; http://www.who.int/wormcontrol/en) and
the ‘Schistosomiasis Control Initiative’ (SCI;
http://www.sci-ntds.org). The renewed impetus for
schistosomiasis control in several countries of sub-
Saharan Africa has generated a greater political
commitment. Within the past ﬁve years, seven
African countries oﬃcially launched their national
control programmes for schistosomiasis and soil-
transmitted helminthiasis (STH); i.e. Uganda,
Cameroon, Burkina Faso, Niger, Mali, Zambia and
Tanzania (Southgate et al. 2005).
From these seven countries, Cameroon is the only
one where the programme was launched and is being
implemented without major external support. In
parallel, there has been considerable commitment to
the control of schistosomiasis in other countries in
Africa. Several countries have developed or revised
their national plans. In this article, a review of ac-
tivities in Cameroon and Coˆte d’Ivoire is made
to assess control progress in these two non SCI-
supported countries.
CONTROL OF SCHISTOSOMIASIS AND STH
IN CAMEROON
Background
In Cameroon, schistosomiasis and STH are import-
ant parasitic diseases. Recent estimates indicate that
at least 2 million people are infected with schistoso-
miasis, 5 million are at risk and more than 10 million
are infectedwith gastrointestinal helminths (Tchuem
Tchuente´ et al. 2003).
In 1983, a pilot project for schistosomiasis control,
funded by the United States Agency for Inter-
national Development (USAID), was set up. Within
this framework a national epidemiological survey of
schistosomiasis and STH was conducted between
1985 and 1987. Overall, 49 divisions, 504 schools and
23850 schoolchildren were investigated. The results
showed the occurrence of Schistosoma haematobium,
S. mansoni, Ascaris lumbricoides, Trichuris trichiura
and Necator americanus as the major helminth spe-
cies. The highest transmission levels of schistoso-
miasis occured in the northern part, whereas STH
were more prevalent in the southern part of the
country (Ratard et al. 1990, 1991; Brooker, Donnelly
and Guyatt, 2000). When considering all these hel-
minthic diseases, no region of the country is spared.
However, this pilot project stopped in 1989 when the
USAID support ended.
Taking advantage of the renewed momentum,
the national programme for the control of schistoso-
miasis and STH was created in March 2003. There
is a strong political commitment from the Minis-
tries of Public Health and Basic Education. These
two ministries work in close collaboration and this
inter-sectorial engagement is consolidated by the fact
that the national steering committee for the control
is co-chaired by the Minister of Public Health and
the Minister of Basic Education, as president and
vice-president, respectively.
The Cameroonian proposal for support to SCIwas
presented by the Minister of Public Health himself
who attended the SCI advocacy meeting in London
in July 2003. Therefore, the non-selection of Cam-
eroon for SCI support came both as a surprise and a
disappointment. Beyond the main ranking criteria,
including the existence of a strategic plan for con-
trol, the strong political commitment and the quality
of the proposal, the SCI selection was ﬁnally made
on a regional combination of three East African
countries and threeWest African countries, with em-
phasis on country-regional collaboration and con-
sortium.
In spite of this, the Cameroonian government
made necessary eﬀorts to ensure the success of the
schistosomiasis and STH control, as it was among
the priority programmes of the country. Hence, the
national control programme was oﬃcially launched
on 25 March 2004.
The action of the programme during the past few
years was intense and multifaceted, with a number of
key achievements. Based on the limited resources
available, the priority activities were centred on three
major activities : (1) the production of various stra-
tegic documents necessary for the implementation of
the activities and advocacy; (2) the advocacy and the
mobilisation of partners and funding; and (3) the
implementation of activities in selected areas.
A strong emphasis was put on advocacy, the re-
sults of which were encouraging for future activi-
ties and plans. The most important was the selection
of Cameroon as the ﬁrst start-up country for
mebendazole donation in Africa, a recent initiative
launched by the pharmaceutical company Johnson
& Johnson (http://www.janssenpharmaceutica.be/
download_Cameroen_N.asp).
With regard to control, a pilot phase was com-
pleted in February 2006 in one health district, where
approximately 20 000 school-aged children were
treated with praziquantel and albendazole. Subse-
quently, the activities were extended to one entire
region of the ten regions in Cameroon, the Adamawa
region in the northern part of the country. This was
implemented with support from partners, including
the World Food Programme (WFP), the Canadian
Co-operation, the United Nations International
Children’s Emergency Fund (UNICEF) and SCI/
Medpharm (which donated the drugs praziquantel
and albendazole). Deworming was conducted in all
500primary schools in this region, and approximately
150 000 school-aged children were treated in May
2006. Overall, 700 head teachers, 500 representatives
of parent teacher associations, and 2500 teachers
were trained. In addition, parasitological surveys
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were conducted in 40 selected schools where stool
and urine samples were collected from a total of
1830 children and examined for schistosomiasis and
STH.
Partnership and scaling-up activities
In2005, Johnson&Johnsonestablishedapartnership
with the Task Force for Child Survival and Devel-
opment to develop a programme to donate me-
bendazole via a multi-disciplinary initiative designed
to address intestinal worm infections in the most
at-risk children of the world. Cameroon was selected
as the start-up country of this drug donation pro-
gramme because of its leadership and commitment to
eliminating infections as a major public health prob-
lem (http://www.janssenpharmaceutica.be/download_
Cameroen_N.asp). This support enabled the national
control programme to scale-up activities rapidly. As
a result, deworming activities were increased to en-
compass all ten regions. In 2007, Cameroon launched
a nationwide deworming campaign, and 4 million
school-aged children were treated. The launching
ceremony allowed the government and partners to
further reaﬃrm their commitment and to galvanise
communities, international development agencies,
non-governmental organisations (NGOs) and other
stakeholders to join in the eﬀort to implement fun-
damental improvements in disease control and pre-
vention.
The country has in place school-based and com-
munity-directed channels and in the programme
teachers and community drug distributors adminis-
ter the drugs to children along with health and hy-
giene education. The major activities conducted are:
(1) training of health and education personnel, (2)
sensitization and education of communities about
the disease, the risks of infection and measures for
prevention, (3) promotion of hygiene, safe water
and sanitation systems in communities, and (4) de-
worming of children.
Furthermore, parasitological surveys were con-
ducted in schools in selected health districts where
stool and urine samples were collected from children,
and examined for schistosomiasis and STH.Detailed
analyses of the data are in progress and results will be
published shortly.
The future action plan of the control programme is
to deworm all school-aged children in endemic zones
twice a year. To achieve this, further support and
partnerships strong will be required to complete and
boost the government eﬀort. Indeed, the control of
NTDs remains a formidable challenge.
CONTROL OF SCHISTOSOMIASIS IN COˆTE
D’IVOIRE
Schistosomiasis has been reported in Coˆte d’Ivoire
since the 1950s. In 1994, the Ministry of Health put
forward a resolution to extend the national control
programme of onchocerciasis and human African
trypanosomiasis to include schistosomiasis and
lymphatic ﬁlariasis (LF) within the framework of the
devolution of the West African Onchocerciasis Con-
trol Programme (OCP). In 1998, a national confer-
ence was held with the aim of launching a national
schistosomiasis control programme. The ﬁrst action
identiﬁed was to update the map of the current dis-
tribution of schistosomiasis across the country. The
mapping of urinary schistosomiasis was facilitated
by the use of a previously validated school-based
questionnaire (N’Goran et al. 1998). Subsequently,
questionnaires were administered to 1337 primary
schools in ﬁve administrative regions in the South
and Centre of the country. More than 130000
schoolchildren were interviewed. The frequency of
reported ‘blood in urine’ was used as a proxy for
S. haematobium, and the results were 31%, 20%, 15%,
13% and 9% in Agneby, Marahoue´, Lacs, Moyen-
Comoe´ and Sud-Comoe´, respectively (N’Guessan
et al. 2007). In addition, parasitological surveys
conducted in school-aged children between 1998 and
2005 revealed prevalences ranging between 5.5% and
38.6% for urinary schistosomiasis, and between
13.6% and 57.4% for intestinal schistosomiasis,
with infections widespread throughout the country
(E. K. N’Goran, unpublished data).
In parallel, a number of speciﬁc research questions
were pursued; among others, the ﬁrst randomized
controlled trials with oral artemether for prevention
of patent infections with either S. mansoni (Utzinger
et al. 2000a) or S. haematobium (N’Goran et al.
2003), and the eﬃcacy of praziquantel and reinfec-
tion patterns in schoolchildren (N’Goran et al. 2001).
In 2006, a clinical trial to assess the eﬃcacy of triben-
dimidine and albendazole against hookworm infec-
tions showed that a single oral dose of tribendimidine
(400 mg) was as eﬃcacious as a single oral dose of
albendazole (400 mg) and without any serious ad-
verse events. The results of this study will be pub-
lished shortly.
After the ﬁrst national conference in 1998, a
national schistosomiasis control programme was
drafted, identifying risk mapping as a ﬁrst priority
area. However, the programme never really started
due to insuﬃcient ﬁnancial support and other con-
straints. Speciﬁcally, towards the end of 1999, a
major socio-political crisis emerged, culminating in
a civil war in September 2002. Despite these un-
favorable contextual factors, major research and focal
control activities targeting schistosomiasis and STH
were pursued by the Universite´ de Cocody-Abidjan
with the support of partners, particularly the Centre
Suisse de Recherches Scientiﬁques, the Swiss Trop-
ical Institute and the Swiss Agency for Development
and Cooperation (SDC).
The 2001 WHA 54.19 resolution was endorsed by
health authorities of Coˆte d’Ivoire and, within this
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control framework, various initiatives targeting
mainly school-aged children were conducted at
diﬀerent scales in endemic areas. Control strategies
and activities not only included chemotherapy-
based morbidity control but also capacity building
of school teachers and community health workers.
In 2001, pilot schistosomiasis control activities
with a partial cost-recovery model were implemen-
ted in primary schools in three districts, namely
Tiassale´, Man and Adzope´. A unit treatment cost
(200 FCFA;yUS$ 0.4) was ﬁxed, based on exten-
sive discussions with schoolteachers and other com-
munity key informants. A proportion of this was
dedicated to the school for hygienic products (25
FCFA), another part (50 FCFA) was used to cover
the distribution cost, and ﬁnally 125 FCFA were
used for drug recovering. A total of 8746 children
were treated.
Regrettably, due to the emergence of the civil war
in September 2002, these activities were interrupted.
With a support from SDC in October 2003, a sys-
tematic deworming campaign was undertaken to
treat school-aged children in the semi-mountainous
region ofMan, western Coˆte d’Ivoire, hyperendemic
for S. mansoni (Utzinger et al. 2000b ; Raso et al.
2005). A total of 352 primary school teachers were
trained for deworming and awareness raising; 349
schools were provided with health education ma-
terials and the standardized praziquantel dose-pole.
A total of 130 000 children were treated with alben-
dazole or mebendazole and 40000 children were
given both praziquantel and albendazole or meben-
dazole. The unit cost of the treatment was estimated
at 165 FCFA per child.
Coˆte d’Ivoire is one of the ten countries partici-
pating in the Global Parasitological Control In-
itiative (GPCI) with the West African Centre for
International Parasites Control (WACIPAC) also
known as Hashimoto Initiative. However, to date,
Coˆte d’Ivoire has not received any ﬁnancial support
from this control initiative for treatment of schisto-
somiasis. Coˆte d’Ivoire’s national school health
programme (PNSSU) with support from WHO,
UNICEF, WFP implemented some schistosomiasis
and STH control projects in selected districts. The
project distributes deworming tablets and micro-
nutrients.Theﬁrst phase of theproject began in 2005.
With the renewed interest in the control of NTDs,
the government of Coˆte d’Ivoire and the Ministry of
Public Health and Hygiene passed a referendum on
21 June 2007 (Nx159 msHP/CAB) to oﬃcially es-
tablish the national schistosomiasis, STH and LF
control programme (PNL-SGF).
PROSPECTS AND OPPORTUNITIES: INTEGRATED
CONTROL OF NTDs
In the developing world, polyparasitism is the norm
rather than the exception (Molyneux et al. 2005;
Fleming et al. 2006). In large parts of Africa, most
children are infected by more than one species of
helminth. These NTDs frequently overlap geo-
graphically and they impose a great burden on poor
populations aﬀecting the same individuals.
Today, robust, low-cost and eﬀective public health
interventions are available to relieve the burden of
parasitic infection and to provide a better quality of
life for people in poor settings. The current strategy
for control is to integrate interventions for multi-
ple diseases (Molyneux et al. 2005). This inte-
grated approach is the basis for cost-eﬀectiveness
and streamlined eﬃciency. According to WHO, the
greatest challenge is to extend regular anthelminthic
drug coverage as a public health intervention to reach
all individuals at risk of the morbidity caused by
helminthic infections. ‘Preventive chemotherapy’
should therefore begin early in life, and every op-
portunity should be taken to reach at-risk popu-
lations (WHO, 2006).
Addressing the NTDs in a more integrated and
holistic way has led to a greater recognition of the
importance of these infections as causes of poverty
and impediments to the well-being of people in de-
veloping countries. During the last decade the in-
creased advocacy for NTD control has generated
commitment and funding opportunities from several
donors. However, the recommendations have yet to
be put into eﬀect and the opportunities are largely
ignored. These infections are still ignored by policy-
makers and politicians who over-focus on unachiev-
able objectives and targets around the ‘big three’
diseases of HIV/AIDS, tuberculosis and malaria
(Molyneux, 2008).
Integrated control strategies of NTDs in Cameroon
The four major NTDs targeted by WHO through
preventive chemotherapy occur in Cameroon, i.e.
schistosomiasis, STH, onchocersiasis and LF. These
diseases have major health and socio-economic re-
percussions and constitute an important public health
problem in the country. Schistosomiasis occurs
mainly in the three northern regions whereas STH
are widely distributed all over the country. On-
chocerciasis occurs in parts of all ten regions of
Cameroon, and it is estimated that 5 million persons
are infected. Loiasis is endemic in seven regions and
co-endemicity of loiasis and onchocerciasis is found
in 85% of health districts where community-directed
treatment with ivermectin (CDTI) is implemented,
leading to some constraints for ivermectin mass
administration (Boussinesq et al. 2003). With re-
gard to LF, this disease is assumed to occur in
many parts throughout the country but the current
infection prevalence and distribution need to be as-
sessed.
Considering the high prevalence and spread
of these diseases and their geographical overlap,
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Cameroon has developed a 2009–2013 strategic plan
for integrated control of these helminthiases. Indeed,
it is estimated that at least three of these common
NTDs are co-endemic in 96 of a total of 174 health
districts.
Currently, there exists several speciﬁc health in-
tervention programmes implemented in Cameroon
by the Ministry of Public Health. Our strategy for
an eﬃcient and cost-eﬀective integrated control of
NTDs is centred on a piggyback approach. There-
fore, the simpliﬁed strategy for the control of hel-
minthiasis in Cameroon is based on a complementary
co-administration of relevant drugs during three
existing integrated national health campaigns.
First, co-administration of ivermectin and
albendazole during the CDTI campaigns is im-
plemented once per year allowing an integrated
treatment of onchocerciasis, LF and STH.
Secondly, co-administration of mebendazole and
praziquantel – where relevant – in school-based de-
worming campaigns, is implemented annually. This
will allow treatment of STH and schistosomiasis.
Importantly, the school-campaign should be con-
ducted at 6-month interval from the CDTI cam-
paign in order to address the bi-annual treatment
requirement for STH.
Finally, distribution of albendazole or meben-
dazole to children aged 1–5 years during child health
week campaigns is implemented twice a year at 6-
monthly intervals and targets children up to 5 years.
This will allow the deworming of all pre-school
children not targeted by the two other campaigns.
Integrated control strategies of NTDs in Coˆte
d’Ivoire
In Coˆte d’Ivoire, epidemiological studies conducted
between 1998 and 2005 revealed STH prevalence
between 4.1% and 39% in school-aged children
(E. K. N’Goran, unpublished data); all are wide-
spread and found throughout the country. LF is also
widespread throughout the country. Though WHO
provided funds to start LF mapping in 2000, map-
ping activities were stopped due to civil unrest in
2002. Out of the 72 districts within Coˆte d’Ivoire, 31
are known to be endemic for LF (prevalence mea-
sured by ICT cards above 1%). LF prevalence ranges
from 0% to 44.4% (in the district of San Pedro of the
Bas-Sassandra region). Eight districts were deter-
mined to be non-endemic and there are still 33 dis-
tricts that require LF prevalence mapping. The
country is also known as endemic for onchocerciasis.
The PNL-SGF has developed a detailed 5-year in-
tegrated national control plan (2008–2012).
CHALLENGES
The control of NTDs is a long-term undertaking,
which involves several challenges. The ﬁrst challenge
will be to mobilise the funds required for success-
ful actions. Therefore, as in almost all developing
countries, Cameroon and Coˆte d’Ivoire will have to
take advantage of the opportunities resulting from
the growing global ﬁnancial resources generated by
the new partnerships and impetus for NTD control.
These changes in the international agenda and the
increase of funding opportunities should provide
leverage for the control of NTDs.
Among other challenges, the most important
are the sustainability of control programmes, the
strengthening of partnerships and institutional ca-
pacities, the implementation of operational research,
monitoring and evaluation, and the co-ordination of
activities (Tchuem Tchuente´, 2006).
Sustainability
To roll back the NTDs, it is necessary to continue
and maintain the implementations of control activi-
ties during very long period. The programme should
be long-term, and ﬁnancial and implementation
plans should be made accordingly. This would avoid
one of the major errors of the past where most of the
programmes were supported by short-term external
funds and stopped immediately when funds ceased.
To ensure sustainability, countries should, from the
beginning, envisage strategies to: (1) keep the mo-
mentum, interest and enthusiasm for the control of
the diseases; (2) organise and ﬁnance in a sustained
way the distribution of drugs to those who need
them; (3) mobilize operational costs for drug distri-
bution, health education materials, baseline data
collection, monitoring and evaluation, etc. ; (4) en-
sure the availability and aﬀordability of the drugs at
community level in endemic areas; (5) integrate
programme activities within the existing health
structures and networks; and (6) strengthen the
health system and national capacity at all levels, es-
pecially in the peripheral and remote areas which
manage the greater number of communities and in-
fected persons.
One of the key questions is how to guarantee the
continuation of control after the decline or inter-
ruption of external funds.
Strengthening of partnership
An eﬃcient control requires multisector collabor-
ation and multilateral funding. No single organiz-
ation can hope to achieve this goal alone. School-aged
children are the target group for schistosomiasis and
STH, so the collaboration between the Ministry of
Health and the Ministry of Education should be re-
inforced. The target group for the diﬀerent ﬁlarial
infections is the entire population and the control
strategy is based on community-directed inter-
ventions, which requires ownership by the communi-
ties and strong partnership with NGOs. Overall,
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partnership with other government departments and
NGOs concerned with water supply, sanitation and
development projects should be developed and re-
inforced.
Strengthening of institutional capacities
The integration of control activities within the health
services is fundamental for the sustainability of the
programme.However,most of the existing structures
do not have the capacity to ensure the implemen-
tation of these activities, leading to programme
failure. Therefore, the strengthening of the health
system is a requirement for the long-term viability
of the control programme. Furthermore, an eﬃcient
participation of schools and communities in the dis-
ease control requires a reinforcement of capacity of
the school system and the community ownership.
Operational research
It is important to support operational research to
fulﬁl gaps and improve the implementations of the
control. For example, the understanding of some key
issues, such as baseline epidemiology, morbidity as-
sessment, drug eﬃcacy testing and monitoring of
drug resistance, is of vital importance.
Monitoring and evaluation
Regular monitoring and evaluation are necessary to
ensure that programmes are eﬃciently implemented
and that the beneﬁciaries gain the maximum beneﬁt.
This is particularly challenging given the diversity of
tools and indicators. Substantial progress has been
made towards the development of standardized tools
for monitoring and evaluating NTD control pro-
grammes. WHO is currently developing guidelines
based on the experience to date with integrated pre-
ventive chemotherapy interventions.
Co-ordination
The main challenge raised by the development of
multiform partnership is to set up clear eﬃcient co-
ordination mechanisms in order to optimize the use
of resources mobilised from various partners. In the
context of multidisease integrated control, there is a
need for setting up a strong national task-force or
steering committee for the co-ordination of activities
of the diﬀerent programmes and stakeholders within
the country. The Ministry of Health should play the
central role in this co-ordination.
CONCLUSION
During the past several decades, many attempts
have been made to control schistosomiasis, STH,
onchocerciasis and LF. Important advances have
been made such as the development of praziquantel,
ivermectin, albendazole and mebendazole, the cur-
rent drugs of choice for these NTDs, which ampli-
ﬁed treatment possibilities to the majority of people
who need it. Although few control successes were
achieved, the global objective is long way oﬀ and
these diseases remain important public health prob-
lems in developing countries. Nevertheless, failures
and experiences of the past allowed an improvement
of control strategies and tools.
Today, there exists a new impetus to global hel-
minth control and a series of favourable factors
for implementing successful control programmes.
These factors are: a clear vision, a strong political
commitment, simple tools, ﬁnancial support from
several governments, the existence of several inter-
national initiatives and funding opportunities and
strategies for cost-eﬀective implementations. Suc-
cessful control across sub-Saharan Africa calls for
strengthening health systems and interventions, en-
suring access to anthelminthic drugs in all health
services, co-implementation and the co-ordinated use
of the diﬀerent anthelminthic drugs, promotion of
access to safe water, adequate sanitation and health
education and mobilization of resources to sustain
control activities.The challenge also includes the sus-
tainability, the integration and the long-term com-
mitment for the control.
At present, we have a great opportunity to take the
challenge and relieve poor communities from disease
burdens that jeopardise their development. There
are several and increasing funding opportunities for
the control of NTDs. There is an urgent need for
well co-ordinated and transparent use of multi-
source funds to increase eﬃciency and to avoid
duplication of eﬀorts. We should act cautiously and
anticipate to avoid past errors.
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